pmid,title,journal,year,drug,disease
40657111,Drug Repurposing by Virtual Screening: Identification of New Already Approved ROCK Inhibitors as Promising Drugs to Target Neurodegeneration.,ACS omega,2025,Ruxolitinib,Alzheimer's
38895380,TYK2 as a novel therapeutic target in Alzheimer's Disease with TDP-43 inclusions.,bioRxiv : the preprint server for biology,2024,Ruxolitinib,Alzheimer's
37189112,Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases.,Cell communication and signaling : CCS,2023,Ruxolitinib,Alzheimer's
36195636,Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms.,Molecular psychiatry,2022,Ruxolitinib,Alzheimer's
33539089,Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.,Journal of medicinal chemistry,2022,Ruxolitinib,Alzheimer's
32829706,Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives.,Journal of neuroinflammation,2020,Ruxolitinib,Alzheimer's
28232234,The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera.,Experimental hematology,2017,Ruxolitinib,Alzheimer's
20878583,American Chemical Society - 240th national meeting - chemistry for preventing and combating disease: part 2.,IDrugs : the investigational drugs journal,2010,Ruxolitinib,Alzheimer's
